Agilent Technologies, Inc. (A) Buy or Sell Stock Guide

Last updated: Sep 12, '19

Are you looking for the analysis of Agilent Technologies, Inc. (A) stock? Are you wondering what the bulls and the bears say about it?

If so, you came to the right place. In this stock guide, we will share with you 7 reasons to buy and 4 reasons to sell A stock. You’ll get a perspective on what the bulls and the bears say about it.

The analysis below may be also helpful to you if you have any of the following questions about A stock:

  • Is A a buy or a sell?
  • Should I sell or hold A stock today?
  • Is A a good buy / investment?
  • What are A analyst opinions, recommendations and ratings?

Let’s start with the bull case. Here are the reasons to buy A stock:

1. Agilent is a well-established leader in many of its core markets. Customer familiarity with Agilent’s instrumentation and services makes market share gains for new entrants difficult.

2. Agilent’s 2014 spin-off of its electronic measurements segment will free up resources to focus on building out the company’s life science, diagnostic, and chemical analysis operations--all higher-growth and more differentiated industries.

3. The 2012 acquisition of Dako enhances Agilent’s access to the higher-growth and larger clinical diagnostics market while boosting the company’s recurring revenue mix.

4. A quarterly revenue growth was 5.90%, higher than the industry and sector average revenue growth (4.63% and 3.10%, respectively). See A revenue growth chart.

5. A forward dividend yield is 0.93%, higher than the industry (0.16%) and sector (0.13%) forward dividend yields. See A forward dividend chart.

6. A forward P/E ratio is 20.73, and it’s low compared to its industry peers’ P/E ratios. See A forward P/E ratio chart.

7. A average analyst rating is Buy. See A analyst rating chart.

Now that you understand the bull case, let’s look at the reasons to sell A stock (i.e., the bear case):

1. A significant portion of Agilent’s business is dependent on research, composed largely of academic and government institutions, which are likely to continue to face budget constraints over the near term.

2. Agilent must continually innovate to stay at the forefront of technological advancement, particularly as it competes with even larger companies with greater resources.

3. Acquisitions and divestments have been central components of Agilent’s strategy, which places high demands on management’s ability to execute market expansion and integration goals.

4. A profitability is declining. The YoY profit margin change was -8.86 percentage points. See A profitability chart.

Now let's look at the key statistics for A:

Metrics A
Price $77.93
Average Price Target / Upside $82.77 / 6.21%
Average Analyst Rating Buy
Industry Diagnostics & Research
Sector Healthcare
Number of Employees 15,300
Market Cap $24.11B
Forward P/E Ratio 22.71
Price/Book Ratio 4.74
PEG 2.38
Revenue (TTM) $5.09B
YoY Quarterly Revenue Growth 5.9%
Profit Margin 21.06%

What are your thoughts on A?

If you liked this analysis, check out Buy or Sell Stock Guides for other stocks.

Comments (0)expand_more